Product Name :
CI994 (Tacedinaline) — HDAC Inhibitor
Description:
CI994 is a potent, selective and orally active histone deacetylase (HDAC) inhibitor. It inhibits HDAC1 (IC50 ~0.57 µM), HDAC2 (IC50 ~0.90 µM) and HDAC3 (IC50 ~1.2 µM). It does not inhibit HDAC6 and HDAC8 (IC50 >100 µM). CI994 mediates G1 cell cycle arrest, inhibits proliferation, and induces apoptosis in tumor cell lines. It has also demonstrated antitumor activity in several tumor models, including the chemo-resistant mouse pancreatic ductal carcinoma as well as the human prostate tumor model LNCaP. Currently CI994 is in phase III clinical trials for lung cancer. In recent publication CI994 could also epigenetically prime the hippocampal transcriptome for reinstated neuroplasticity and lead to increased neuroplasticity during memory extinction. This suggests applying HDACis during memory reconsolidation might constitute a treatment option for remote traumata.
CAS:
112522-64-2
Molecular Weight:
269.30
Formula:
C15H15N3O2
Chemical Name:
4-acetamido-N-(2-aminophenyl)benzamide
Smiles :
CC(=O)NC1C=CC(=CC=1)C(=O)NC1=CC=CC=C1N
InChiKey:
VAZAPHZUAVEOMC-UHFFFAOYSA-N
InChi :
InChI=1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
CI994 is a potent, selective and orally active histone deacetylase (HDAC) inhibitor. It inhibits HDAC1 (IC50 ~0.57 µM), HDAC2 (IC50 ~0.90 µM) and HDAC3 (IC50 ~1.2 µM). It does not inhibit HDAC6 and HDAC8 (IC50 >100 µM). CI994 mediates G1 cell cycle arrest, inhibits proliferation, and induces apoptosis in tumor cell lines.{{Amisulpride} medchemexpress|{Amisulpride} GPCR/G Protein|{Amisulpride} Biological Activity|{Amisulpride} Formula|{Amisulpride} manufacturer|{Amisulpride} Autophagy} It has also demonstrated antitumor activity in several tumor models, including the chemo-resistant mouse pancreatic ductal carcinoma as well as the human prostate tumor model LNCaP.{{Mucicarmine} web|{Mucicarmine} {Fluorescent Dye}|{Mucicarmine} Technical Information|{Mucicarmine} In stock|{Mucicarmine} custom synthesis|{Mucicarmine} Epigenetic Reader Domain} Currently CI994 is in phase III clinical trials for lung cancer.PMID:23453497 In recent publication CI994 could also epigenetically prime the hippocampal transcriptome for reinstated neuroplasticity and lead to increased neuroplasticity during memory extinction. This suggests applying HDACis during memory reconsolidation might constitute a treatment option for remote traumata.|Product information|CAS Number: 112522-64-2|Molecular Weight: 269.30|Formula: C15H15N3O2|Chemical Name: 4-acetamido-N-(2-aminophenyl)benzamide|Smiles: CC(=O)NC1C=CC(=CC=1)C(=O)NC1=CC=CC=C1N|InChiKey: VAZAPHZUAVEOMC-UHFFFAOYSA-N|InChi: InChI=1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20)|Technical Data|Appearance: Solid Power.|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO up to 100 mM|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined.|HS Tariff Code: 382200|How to use|In Vitro:|CI994 was used at 2.5-10 µM in vitro and cellular assays.|In Vivo:|CI994 was administered to mice via oral gavage (PO) or intraperitoneal injection (IP) at 5-35 mg/kg once per day.|References:|Kraker AJ, et al. Modulation of histone acetylation by [4-(acetylamino)-N-(2-amino-phenyl) benzamide] in HCT-8 colon carcinoma. (2003) Mol Cancer Ther. 2(4):401-8.Loprevite M, et al. In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines. (2005) Oncol Res. 15(1):39-48.Products are for research use only. Not for human use.|Documents||